Omicron News and Research

RSS
Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

SARS-CoV-2 mRNA vaccines may prevent COVID-19-associated mechanical ventilation and death

SARS-CoV-2 mRNA vaccines may prevent COVID-19-associated mechanical ventilation and death

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2

Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2

Natural infection versus messenger RNA vaccination-induced immune protection

Natural infection versus messenger RNA vaccination-induced immune protection

Novel monoclonal antibody found to have substantial neutralizing capacity against SARS-CoV-2 Omicron variant

Novel monoclonal antibody found to have substantial neutralizing capacity against SARS-CoV-2 Omicron variant

The significance of bedside lung ultrasound on predicting COVID-19-related hospitalization in children

The significance of bedside lung ultrasound on predicting COVID-19-related hospitalization in children

New model suggests long-range transmission of SARS-CoV-2

New model suggests long-range transmission of SARS-CoV-2

Novel nanoparticle-based COVID vaccines induce long-term neutralizing antibody response

Novel nanoparticle-based COVID vaccines induce long-term neutralizing antibody response

COVID booster vaccination more effective relative to 2-dose series

COVID booster vaccination more effective relative to 2-dose series

The relative performance of OPS, NPS, and saliva for detecting the Delta and Omicron SARS-CoV-2 variants

The relative performance of OPS, NPS, and saliva for detecting the Delta and Omicron SARS-CoV-2 variants

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Molecular dynamic simulations unveil conformational dynamics of SARS-CoV-2 spike protein RBD and ACE2 receptor

Molecular dynamic simulations unveil conformational dynamics of SARS-CoV-2 spike protein RBD and ACE2 receptor

Early treatment of COVID-19 in high-risk children and adolescents infected with the Omicron variant of SARS-CoV-2

Early treatment of COVID-19 in high-risk children and adolescents infected with the Omicron variant of SARS-CoV-2

Length of stay distributions of hospitalized COVID-19 cases during a mixed Omicron-Delta epidemic in Australia

Length of stay distributions of hospitalized COVID-19 cases during a mixed Omicron-Delta epidemic in Australia

Posaconazole found to be effective as a small molecule fusion inhibitor against SARS-CoV-2 variants

Posaconazole found to be effective as a small molecule fusion inhibitor against SARS-CoV-2 variants

Research characterizes efficacy of various COVID vaccines against Omicron BA.1 and BA.2

Research characterizes efficacy of various COVID vaccines against Omicron BA.1 and BA.2

SARS-CoV-2 infection risk among dialysis patients during Omicron surge

SARS-CoV-2 infection risk among dialysis patients during Omicron surge

Is COVID-19 on the verge of ending?

Is COVID-19 on the verge of ending?

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.